Cardiac complication after experimental human malaria infection: a case report
<p>Abstract</p> <p>A 20 year-old healthy female volunteer participated in a clinical Phase I and IIa safety and efficacy trial with candidate malaria vaccine <it>Pf</it>LSA-3-rec adjuvanted with aluminium hydroxide. Eleven weeks after the third and last immunization she...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-12-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/8/1/277 |